Genetic Technologies Limited operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Genetic Technologies Limited with three other
pharmaceutical manufacturers in Australasia:
MGC Pharmaceuticals Ltd
(2017
sales of 247,500.00 Australian Dollars [US$189,510.75 ]
),
Bod Australia Ltd
(352,877.00 Australian Dollars [US$270,197.92 ]
), and
Creso Pharma Ltd
(342,251.00 Australian Dollars [US$262,061.59 ]
).
Sales Analysis.
Genetic Technologies Limited reported sales of A$518,506.00 (US$397.02 thousand)
for the
fiscal
year ending
June of 2017.
This
represents
a
sharp
decrease of 37.1%
versus 2016, when the company's sales were A$824,586.00 .